Related Experiment Video
Updated: Jun 5, 2026

Extracellular Vesicle Tissue Factor Activity Assay
Published on: December 29, 2023
Tissue factor pathway inhibitor endocytosis
1Departments of Pediatrics and Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Abstract:
Tissue factor pathway inhibitor (TFPI), a 42 kD protein, provides the physiological inhibition of tissue factor initiated coagulation by inhibition of both factor Xa and factor VIIa/tissue factor. In plasma, most TFPI is lipoprotein bound with an additional "releasable" pool bound to the endothelial cell surface. TFPI clearance is via receptor mediated endocytosis into liver. Heparin sulfate proteoglycans and LRP (low density lipoprotein receptor-related protein), an extremely large (∼600 kD) cell surface protein, primarily mediate this clearance, although additional TFPI binding sites and endocytosis pathways exist. (Trends Cardiovasc Med 1997; 7:234-239). © 1997, Elsevier Science Inc.
Insights
Tissue factor pathway inhibitor (TFPI) regulates blood clotting by inhibiting key factors. It is cleared from circulation primarily by liver endocytosis, mediated by specific cell surface proteins.
Area of Science:
- Biochemistry
- Hematology
- Cell Biology
Background:
- Tissue factor pathway inhibitor (TFPI) is a critical regulator of the extrinsic coagulation cascade.
- TFPI inhibits coagulation initiation by targeting factor Xa and the factor VIIa/tissue factor complex.
- TFPI exists in plasma, bound to lipoproteins, and in a releasable pool on endothelial cells.
Purpose of the Study:
- To elucidate the physiological role and clearance mechanisms of TFPI.
- To identify the primary mediators of TFPI clearance from circulation.
Main Methods:
- Review of existing literature on TFPI function and pharmacokinetics.
- Analysis of TFPI binding interactions and cellular uptake pathways.
Main Results:
- TFPI primarily circulates bound to lipoproteins, with a significant pool releasable from endothelial surfaces.
- Heparin sulfate proteoglycans and the low-density lipoprotein receptor-related protein (LRP) are key mediators of TFPI clearance.
- Receptor-mediated endocytosis into the liver is the main route for TFPI elimination.
Conclusions:
- TFPI plays a vital role in controlling coagulation initiation.
- Liver uptake via LRP and proteoglycans is the predominant mechanism for TFPI clearance.
- Understanding TFPI clearance is crucial for its therapeutic applications in hemostasis.
Related Concept Videos
Receptor-mediated Endocytosis
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Receptor-Mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
The Early Endosome: Endocytosis of Transferrin
The Extrinsic Apoptotic Pathway
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

